Certara’s $287.5 Million Secondary Offering

Simpson Thacher represented Certara, Inc. (“Certara”) and an entity affiliated with EQT AB (“EQT”) in the transaction.

The secondary offering of common stock of Certara by EQT and other selling stockholders, consisted of 11,500,000 shares of Certara’s common stock raised approximately $287.5 million in gross proceeds, with the selling stockholders receiving all of the proceeds from the offering.

Certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.

The Simpson Thacher team included Bill Brentani (Picture), Kelli Schultz, Jonathan Kachiu and Bori Celia Ha (Capital Markets); and Jonathan Goldstein, Jonathan Cantor and Abigail Hopper (Tax).

Involved fees earner: William Brentani – Simpson Thacher & Bartlett; Jonathan Cantor – Simpson Thacher & Bartlett; Jonathan Goldstein – Simpson Thacher & Bartlett; Bori Ha – Simpson Thacher & Bartlett; Abigail Hopper – Simpson Thacher & Bartlett; Jonathan Kachiu – Simpson Thacher & Bartlett; Kelli Schultz – Simpson Thacher & Bartlett;

Law Firms: Simpson Thacher & Bartlett;

Clients: Certara; EQT Partners AB;

Author: Martina Bellini